Ophthalmology   

If so, when do you recommend timing for the cataract surgery? 

Patient is asymptomatic. Labs showed +P-ANCA 1:160. Negative MPO and PR3.

Patient has failed methotrexate and adalimumab. 

Patient failed topical ocular therapies, methotrexate, azathioprine.

Is the approach different from uveitis immunosuppression?

Are there specific features that suggest drug-induced uveitis versus de novo uveitis?

Are IL-17 or IL-23 inhibitors helpful?

Patient was previously well controlled on methotrexate, which was discontinued during cancer treatment.